Biogenic amine levels in the mid-term human fetus

Area of Science:

• Neuroscience
• Developmental Biology
• Biochemistry

Background:

• Biogenic amines play crucial roles in neurotransmission and brain development.
• Understanding their presence and distribution during fetal development is essential for insights into neurodevelopmental processes.

Purpose of the Study:

• To quantify the concentrations of key biogenic amines in fetal brain tissue and cerebrospinal fluid (CSF).
• To investigate the distribution of these amines in different brain regions (hypothalamus and cortex).
• To determine if there are sex-based differences in amine concentrations during mid-gestation.

Main Methods:

• Spectrophotofluorometric assays were employed to measure concentrations of norepinephrine (NA), dopamine (DA), serotonin (5-HT), and 5-hydroxyindoleacetic acid (5-HIAA).
• Tissue extracts from the hypothalamus and cortex, along with CSF samples, were analyzed from midterm fetuses.
• Statistical analysis was performed to compare concentrations between brain regions and sexes.

Main Results:

• Biogenic amines were detected in fetal brain tissue as early as 10.5 weeks gestation.
• Concentrations of DA and 5-HT were significantly higher in the hypothalamus compared to the cortex (P < 0.05).
• NA and 5-HIAA concentrations were similar in both the hypothalamus and cortex. No significant sex differences were observed in amine levels.

Conclusions:

• The study demonstrates the early presence and regional distribution of critical biogenic amines in the developing human fetal brain.
• Findings suggest specific developmental patterns for certain neurotransmitters in distinct brain areas during mid-gestation.
• The absence of sex differences indicates a conserved neurochemical environment between sexes at this developmental stage.